TrialBMC cancer2022

Efficacy and safety of pomalidomide and low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma: a multicenter, prospective, single-arm, phase 2 trial.

Wei-Jun Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.